Danaher Corporation (BIT:1DHR)

Market Cap	122.06B
Revenue (ttm)	20.50B
Net Income (ttm)	2.91B
Shares Out	n/a
EPS (ttm)	4.02
PE Ratio	41.90
Forward PE	24.36
Dividend	0.78 (0.46%)
Ex-Dividend Date	Jun 26, 2025

Volume	140
Average Volume	25
Open	171.76
Previous Close	172.42
Day's Range	167.30 - 171.76
52-Week Range	159.04 - 261.90
Beta	n/a
RSI	33.12
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD